Theme: Research and Evaluation in Biomedicine and Pharmacotherapy

Biomedicine 2018

Scientific Program

Renowned Speakers

Ernesto Delgado Cidranes
Advanced Pain & Aesthetic Management Center Madrid
Spain

Lia Monica Junie
University of Medicine and Pharmacy
Romania

Ian James Martins
Edith Cowan University
Australia

Sergey Suchkov
I.M.Sechenov First Moscow State Medical University
Russia

Marion G Ben Jacob
Mercy College
USA

Sasidharan Sreenivasan
USM
Malaysia

Stef Stienstra
Dutch Armed Forces / Royal Dutch Navy
Netherlands

Manoj Kumar Bhat
National Centre for Cell Science
India

Jianguo Yang
CEO , TAYU Biotech
China

Gaston Hui Bon Hoa
National Institute of Health and Medical Research
France

K C Santosh
University of South Dakota
USA

Ning-Sun Yang
Agricultural Biotechnology Research Centre
Taiwan

Biomedicine 2018

The Organizing Committee of Conference Series llc Ltd invites all the participants across the globe to attend the International Conference on Biomedicine & Pharmacotherapy on August 06-07, 2018at Osaka, Japan.

Track-1: Biomedicine

Biomedicine (i.e. medical biology) is a branch of medical science that applies organic and physical principles to clinical practice. The branch especially applies to biology and physiology. Biomedicine also can relate to many other categories in health and biological related fields. The therapy used in pharmaceutical drugs is known as pharmacotherapy. It is distinguished from other therapy like surgical, radiation and physical therapy. Biomedicine involves the study of (pathos-) physiological processes with methods from biology and physiology. Approaches range from understanding molecular interactions to the study of the consequences at the in vivo level. These processes are studied with the particular point of view of devising new strategies for diagnosis and therapy. The application of development and pathological processes in humans, animals and cellular models is known as system medicine. Whereas systems biology aims at modelling exhaustive networks of interactions (with the long-term goal of, for example, creating a comprehensive typical of the cell), mainly at intra-cellular level, it also emphasizes the models of tissue, cell, organ, ecosystem by integration of factors into models that reveal the biological processes.

8th Global Pharmacovigilance & Drug Safety Summit, April 17-18, 2017 Bali, Indonesia; 8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany

Track-2: Biomedical Statistics

The process used for collection, analysis and interpretation of data especially related to human biology, health and medicine. In a defined population the pattern, causes and effects of health and disease is studied and analysed by a process called epidemiology. The art of science that prevent disease, prolonging life and promoting human health through original efforts and informed choices of society, organizations, public and private, communities and individuals is referred to public health. The application of medical knowledge to the investigation of crime, particularly in establishing the causes of injury or death. The safety and effectiveness of medications, diagnostic products and treatment intended for human use is determined by a process called as clinical research.

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 13-15, 2017 London, UK; 10th Asia-Pacific Pharma Congress July 24-26, 2017 Melbourne, Australia; 6th World Congress on Pharmacology August 07-09, 2017 Paris, France.

Track-3: Medical Devices

The device can be used alone or in combination in the field of instrument, software including the software intended and its manufacture to be used specifically for diagnostic and therapeutic purposes and necessary for its proper application to be used for human beings. Medical devices vary according to their intended use and indications. Examples range from simple devices such as tongue depressors, medical thermometers, and disposable gloves to advanced devices such as computers which assist in the conduct of medical testing, implants, and prostheses. In the field of mechanical engineering the design of medical devices constitutes a major segment.

Track-4: Biomedical model

For the diagnosis of disease, the biomedical model of medicine play an important role between doctor and patient. The biological factors only focused by biomedical model since mid-19^th century. The biomedical model gives the freedom to health from disease, pain or detect for making the condition of human healthy. The model's focus on the physical processes (for example, pathology, biochemistry and physiology of a disease) does not take any role for social factors or individual. the biomedical model does not consider diagnosis, which affects treatment of the patient, to be the result of a negotiation.

Track-5: Biomedical Diagnostics

Biomedical diagnostics is the study of procedures that provide information to aid the term is used, but in the case of a wrong diagnosis, the individual's actual disease or condition is not the same as the individual's diagnosis. Laboratory diagnosis is the process by which the disease is diagnosed in laboratory except physical examination. Radiology diagnosis is the process by which diagnosis occur by on the results from medical imaging studies. screening, detection, diagnosis and monitoring of disease. The diagnostic procedure may be carried out by physician, health care scientist, dentist, and pediatrist. According to individual medical conditions the diagnostic procedure can be separate.

Track-6: Biomedical Science

Biomedical science is the study of the human body, its structure and function in health and disease. Medical microbiology is a Study of inhibition, diagnosis and treatment of various infectious diseases is related to medical microbiology. In addition, for the improvement of health this field of science studies various clinical applications of microbes. Clinical Virology is the Isolation of one or more several viruses responsible for human pathology by direct or indirect techniques (cellular Cultures, serologies, biochemistry, molecular biology) is related to clinical virology. Clinical epidemiology is the study of disease and its analysis like pattern, cause and effects is related to this epidemiology. Genetic epidemiology is the study of the role of genetic factors in determining health and disease in families and in populations, and the interplay of such genetic factors with environmental factors.

Track-7: Computational Biomedicine

In order to improve the diagnosis, prediction and treatment of complex medical diseases a process is developed known as computational biomedicine. Computational biomedicine is the name given to the use of computer-based tools and approaches to simulate and model the human body in health and disease. In the European Union, this new science has become synonymous with the concept of the virtual physiological human (VPH). More specifically, however, the name VPH is given to an ambitious initiative, funded through Framework Seven but building on work funded through earlier frameworks and external initiatives.

Track-8: Molecular Biomedicine

The process by which molecular structures and mechanisms are desired in the field of using physical, chemical, biological, biostatics, and medical techniques are known as molecular medicine. This field mainly focused on cellular and molecular phenomenon rather than focus on patients and organs. The distribution of medicine to each individual cell just as oxygen coined by Sanjab Jacab.It also identify the genetic errors of disease and develop molecular.

Track-9: Personalised medicine

The patients are separated into different groups according to their medical decision, practices, intervention or their risk of disease, the term is used known as personalized medicine. It is also called precision medicine, stratified medicine and p4 medicine. In personalised medicine, based on the context of a patient’s genetic content or other molecular or cellular analysis diagnostic testing is often employed for selecting appropriate and optimal therapies.

Track-10: Frontiers in Biomedicine

By using the chemical physical and biological methods the organs and the tissue systems can be developed the process is known as tissue system. Pathology is both a pure and an applied science and in the NHS setting is responsible for providing diagnostic laboratory tests on tissue, blood and other fluids, and for using laboratory tests to assess patients’ responses to treatment. Today, cell biology is a major driver of all aspects of biomedicine. The diagnosis of a disease increasingly relies on genetic, molecular, and cellular markers, and drug discovery has shifted from blind screening to targeted molecular design informed by our genetic, molecular, and cellular understanding of a disease. The technology for the domain of living and biological systems for the application of engineering and technology is known as biomedical engineering. The relationship between the parasite and host and their study is known as parasitology. virology is a twentieth-century science that deals with viruses and viral diseases. Physiology is the study of the relationship between an organism's form and its function. The best-known branch of physiology deals with the mechanical function of limbs and joints. However, the study of physiology also includes the function of organs and tissues, as well as the biochemical systems within and between cells. The application of development and pathological processes in humans, animals and cellular models is known as system medicine.

Track-11: Pharmacotherapy

Among physicians, medical therapy refers specifically to pharmacotherapy as opposed to clinical or other therapy sometimes the term is used. for example, in oncology, medical oncology is thus distinguished from surgical oncology. Economical use of pharmaceutical drugs is ensured by pharmacist by the process pharmacotherapy. knowledge, training and experience in biomedical, pharmaceutical and clinical sciences the skills required to function as a pharmacist require. The pharmacotherapy is improved by pharmacology. The process used for collection, analysis and interpretation of data especially related to human biology, health and medicine.

Track-12: Biopharmaceutics

Biopharmaceutics examines the interrelationship of the drug on the basis of physical/chemical properties, the dosage form (drug product) in which the drug is given, and the route of administration on the rate and extent of systemic drug absorption. The importance of the drug substance and the drug formulation on absorption, and in vivo distribution of the drug to the site of action, is described as a sequence of events that precede elicitation of a drug's therapeutic effect.

Drugs are substances intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. Drugs are given in a variety of dosage forms or drug products such as solids (tablets, capsules), semisolids (ointments, creams), liquids, suspensions, emulsions, etc, for systemic or local therapeutic activity. Drug products can be considered to be drug delivery systems that release and deliver drug to the site of action such that they produce the desired therapeutic effect and are also designed specifically to meet the patient's needs including palatability, convenience, and safety.

Track-13: Pharmacological Sciences

The study of drug action concerned with Pharmacology is the branch of biology , where a drug can be broadly defined as any man-made, natural, or endogenous (from within body) molecule which exerts a biochemical or physiological effect on the cell, tissue, organ, or organism (sometimes the word pharmacon is used as a term to encompass these endogenous and exogenous bioactive species).The factor affect normal or abnormal biochemical function that occur between a living organism and chemicals More specifically, it is the study of the interactions . If substances have medicinal properties, they are considered pharmaceuticals. The basis of signal transduction/cellular communication drug composition and properties, synthesis and drug design, molecular and cellular mechanisms, organ/systems mechanisms, molecular The field encompasses diagnostics, interactions, toxicology, chemical biology, therapy, and medical applications and antipathogenic capabilities.

Related Pharma Conferences | Pharmaceutical Meetings:

Track-14: Pharmaceutical Technology

Pharmaceutics is the discipline of pharmacy that deals with the process of turning a new chemical entity (NCE) or old drugs into a medication to be used safely and effectively by patients. the science of dosage form design is also related to Pharmaceutical technology. There are many chemicals with pharmacological properties, but need special measures to help them achieve therapeutically relevant amounts at their sites of action. The method for the formulation of drugs is designed by the pharmaceutics for the delivery and disposition in the body which play a major role. Pharmaceutics deals with the formulation of a pure drug substance into a dosage formPure drug substances are usually white crystalline or amorphous powders. most drugs today are administered as parts of a dosage form. as it is very common for pharmacists to dispense drugs, than Historically before the advent of medicine. The clinical performance of drugs depends on their form of presentation to the patient.

Track-15: Nanotechnology

At the level of atomic, molecular and macromolecular the development of engineered devices is known as Nanotechnology. Nanoparticles have potential application in medical field including diagnostics and therapeutics. Nanotechnology devices are being developed for diagnosis of cancer and infectious diseases which can help in early detection of the disease.In the field of drug discovery, drug delivery and gene delivery the advances of Nanotechnology have been seen. Nanoparticles can be constructed by various methodology so that effect can be targeted at desired site. In this review, the application of Nanoparticles in medicine for diagnostic and therapeutic which can be used at clinical level.

Track-16: Pharmacognosy

Drugs derived from plants or other natural sources is the study of medicinal branch which is related to Pharmacognosy. The American Society of Pharmacognosy defines pharmacognosy as "the study of the physical, chemical, biochemical and biological properties of drugs, drug substances or potential drugs or drug substances of natural origin as well as the drugs from natural sources”. It is also defined as the study of crude drugs.Although most pharmacognostic studies focus on plants and medicines derived from plants, other types of organisms are also regarded as pharmacognostically interesting, in particular, various types of microbes (bacteria, fungi, etc.), and, recently, various marine organisms. secondary metabolites i.e. study of natural product molecules the term defines as Pharmacognosy as that are useful for their medicinal, ecological, gustatory, or other functional properties.

Track-17: Immunopharmacology

The application of immunological techniques and effects of drugs the branch concerned with Immunopharmacology especially on the immune system. Prior to the designation of immunity from the etymological root immunise, which is Latin for "exempt"; early physicians characterized organs that would later be proven as essential components of the immune system. The important lymphoid organs of the immune system are the thymus and bone marrow, and chief lymphatic tissues such as spleen, tonsils, lymph vessels, lymph nodes, adenoids, and liver., organs including the thymus, spleen, bone marrow, lymph nodes and other lymphatic tissues as a part of immune system can be surgically excised When health conditions worsen to emergency status for examination while patients are still alive. Applications on smart phones may also be used to assist with patient management.

Track-18: Industrial Pharmacy

Involvement of medication that discovers, develops, produces, and markets drugs or pharmaceutical drugs is the branch related to Pharmaceutical industry. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy and drugs. Now a day the root of pharmaceutical industry emphasizes on two sources. The first of these were local apothecaries that expanded from their traditional role distributing botanical drugs such as morphine and quinine to wholesale manufacture in the mid 1800s.The drugs which are discovered from the plant depends particularly with the isolation of morphine, analgesic and sleep-inducing agent from opium, The name Morpheus is given by the German assistant apothecary Friedrich Sertürner, who named the compound after the Greek god of dreams, Morpheus. Multinational corporations including Merck, Hoffman-La Roche, Burroughs-Welcome (now part of Glaxo Smith Kline), Abbott Laboratories, Eli Lilly and Upjohn (now part of Pfizer) began as local apothecary shops in the mid-1800s. By the late 1880s, German dye manufacturers had perfected the purification of individual organic compounds from coal tar and other mineral sources and had also established rudimentary methods in organic chemical synthesis. The development of synthetic chemical methods allowed scientists to systematically vary the structure of chemical substances, and growth in the emerging science of pharmacology expanded their ability to evaluate the biological effects of these structural changes.

Related Societies and Associations: American Society of Consultant Pharmacists , American College of Clinical Pharmacy

Welcome Message
Bio Medicine 2018

Dear Colleagues, Scientists and Friends,

We at Sechenov University and Moscow Engineering Physical Institute (MEPhI), Russia, and United Cultural Convention (UCC, Cambridge, UK), look forward to welcoming you to International Conference on Biomedicine & Pharmacotherapy, to be held in Osaka as one of the historical, political and cultural centers of Japan.

The Conference is designed to canvas a variety of contemporary pharmacotherapeutic considerations of interest to medical and biopharma world as well as other allied healthcare providers. The Conference will thus feature a highly interactive and multi-disciplinary Program including initiatives to address the entire Biomedical pathways to the latest fundamental, applied and translational applications in Pharmacotherapy.

Medical doctors, scientists, nurses, health professionals, government officials, partners from the industry, health advocacy groups and healthcare givers will come together in order to obtain and exchange information on advances in targeted treatment and the management of chronic disorders being controlled via applications of canonical thera-peutic and newest preventive, prophylactic and rehabilitative manipulations. Today a combinatorial approach to tailor personalized treatment protocol is becoming the stra-tegic mainstream of clinical and translational research and practice, and significantly influences the future of the care based on the evidence-based applications, the needs and the challenges in daily clinical practice and the strategies of biopharma and healthcare industry as well.

Let me as the Russian Ambassador managing the newest Center for Personalized Medi-cine at Sechenov University and Department for Translational Medicine within Moscow Engineering Physical Institute ask you to submit your latest research results and outcome of your clinical experience for presentation. Your active contribution will be crucial to the success of the Conference and its impact on our global mission to prevent, to treat and to rehabilitate chronic disorders. Together, we will become a stronger voice and global force with the ultimate goal of succeeding in decreasing the world-wide burden of the illness.

You will be also able to discuss challenges encountered and solutions adopted and have opportunities to establish productive new academic, clinical and industry collaborations. The Conference provides a unique opportunity for the leaders, educators, clinicians, bioengineers and biodesigners, experts and scholars from all over the world to convene novel ideas on crucial issues and trends in the area of biomedicine. The Conference will thus provide enough space for discussion, meetings and workshops in order to allow a close contact between speakers and visitors.

We hope that, despite the intense Program, you will be able to get some glimpses of fan-tastic Osaka which has played host to many international organizations and events. We do hope that you will enjoy the Conference and that your interaction with your col-leagues will stimulate a creative exchange of ideas and will be personally rewarding!

Dr Sergey Suchkov, MD, PhD

Professor in Medicine,
Director, Center for Personalized Medicine,
Sechenov Univercity, and Chair,
Department for Translational Medicine,
Moscow Engineering Physical Institute (MEPhI), Moscow, Russia,
Secretary General, United Cultural Convention (UCC), Cambridge, UK

Conference Series Ltd proudly announces the International Conference on Biomedicine & Pharmacotherapy which will be held during August 06-07, 2018 at Osaka, Japan. The theme of conference is “Research and Evaluation in Biomedicine and Pharmacotherapy”. Conference Series Ltd provides a Global Platform for Pharmacologist, Biotech, Medical and Healthcare Professionals to Exchange Ideas, Knowledge and Networking at its International Conference.

Biomedicine 2018 focuses on the importance to understand drugs and how they can affect human physiology. It is with better understanding of Pharmacology one can know the right dosage and dosage forms of drugs. More research in Biomedicine and pharmacotherapy deals with identifying and responding to drug interactions and its side effects along with its mechanism of action, its therapeutic index and thereby treat accordingly. More intensive study with the interaction between drug and its therapeutic effect helps to identify the properties of ideal drugs.

Why to attend???

Join your peers around the world focused on learning about Biomedicine and Pharmacotherapy and related advances, which is your single best opportunity to reach the largest assemblage of participants from the Biomedicine and Pharmacology community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 3-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Biomedicine and Pharmacotherapy are hallmarks of this conference.

Keynote presentation along with interactions to galvanize the scientific community.
Workshop and symposiums to reach the largest assemblage of participants from the Pharma community.
A wide track of exhibitors to showcase the new and emerging technologies.
Platform to global investment community to connect with stakeholders in Pharma sector.
Young Scientist/ Investigators Award geared towards best budding young research.
Links to the political marketing resources in order to expand your business and research network.
Triumph of Awards, Certificates and CPD Credits recognizes your commitment to your profession to encourage the nascent research.

Target Audience:

Scientists
Pharmacists
Scholars from Pharmaceutical backgrounds
Business Tycoons
Students, Scientists, Researchers, and Faculty of Pharmaceutical Sciences, Universities and Medical Colleges
Researchers from Pharmaceutical Companies, Pharmacy Associations and Societies
Health professionals
Business development professionals, Consultants and Pharma service providers
Quality control specialist
Graduates and post graduates in industrial pharmacy
Medical Devices Manufacturing Companies, CRO
Data Management Companies.
Pharmaceutical legislators and regulators

Summary:

Biomedicine (i.e. medical biology) is a branch of medical science that applies organic and physical principles to clinical practice. The branch especially applies to biology and physiology. Biomedicine also can relate to many other categories in health and biological related fields. Among physicians, medical therapy refers specifically to pharmacotherapy as opposed to clinical or other therapy sometimes the term is used. for example, in oncology, medical oncology is thus distinguished from surgical oncology. Biomedicine and Pharmacotherapy Conference deals with topics like Biomedical Statistics, Medical Devices, Biomedical model, Biomedical Diagnostics, Biomedical Science, Computational Biomedicine, Molecular Biomedicine, Personalized medicine, Biomedicine frontier, Pharmacotherapy, Biopharmaceutics, Pharmacological Sciences, Pharmaceutical Technology, Nanotechnology, Pharmacognosy, Immunopharmacology, Industrial Pharmacy and more. Approaches range from understanding molecular interactions to the study of the consequences at the in vivo level. These processes are studied with the particular point of view of devising new strategies for diagnosis and therapy. Economical use of pharmaceutical drugs is ensured by pharmacist by the process pharmacotherapy. knowledge, training and experience in biomedical, pharmaceutical and clinical sciences the skills required to function as a pharmacist require.

The Future of Biomedicine and Pharmacotherapy' gives fully fledged understanding into the compelling utilization of Pharmacotherapy all through drug discovery, preclinical development and clinical trials. The report also highlights the use of Medicine and Pharmacotherapy in maximizing and sustaining revenues post-marketing and in the development of clinical diagnostics.

Importance & Scope:

Biomedicine and Pharmacotherapy is now being extensively used in pharmaceutical and biotechnology industries for biomarker and drug discovery; pharmaceutical and biotechnology industries are expected to grow at a high rate in coming years, which is expected to boost the growth of the market.

The National Institutes of Health said that they are to invest $14.3 million for Pharmacotherapy research, potentially investing more than $51.4 million over five years, to accelerate an emerging field of drug research known as Pharmacotherapy. As per National Centre for Biotechnology Information. Pharmacotherapy has matured over the past 10 years. Over 300 studies have been completed over the past 5 years.

Why Japan?

Japan is the second largest Life science market in the world after USA, Occupying about 10% of Market in each of the global drug and Medical devices market. According to Data monitor, the Japanese biotechnology market had a total revenue of $ 43.3 Billion in 2013. By 2018, the market is expected to grow to $ 53.8 Billion.The Japanese pharmaceutical market is the world’s second-largest, with 2013 sales estimated at $115 billion. Japan accounts for a little less than 10 percent of the global Pharma market, compared with 38.4 percent for the U.S. and 20.7 percent for Western Europe. The Japanese market is a promising region for Biotechnology companies, as a high amount of Pharmaceutical research is being conducted in the country.

Why to attend???

Meet Your Target Market With recent business reports on Medicine and Pharmacy making news which manifests the tremendous growth in market value for Pharmacotherapy till 2019. Since Biomedicine and Pharmacotherapy interrelated with sciences like Biomedical technology, Molecular medicine, precision Medicine, Biopharmaceutics, Immunopharmacology, Pharmacological sciences and Industrial pharmacy, it would be a great opportunity for companies dealing with Analytical instruments useful in these fields. Also, many upcoming students and researchers can benefit themselves by participating world class International workshops, symposia during the conference which will be conducted by experts in the respective fields.

Major Biomedicine and Pharmacotherapy Related Associations around the Globe:

Biomedicine and Pharmacotherapy Society

National Association for Biomedical Research (NABR)

Alabama Society for Healthcare Engineering,

Biomedical Engineering Society (BMES)

American Statistical Association (ASA)

American Medical Informatics Association

Generic Pharmaceutical Association (GPhA)

American Institute for Medical and Biological Engineering

American Society for the Advancement of Pharmacotherapy (ASAP)

National Community Pharmacists Association (NCPA)

Academy of Managed Care Pharmacy (AMCP)

American Society of Pharmacognosy

Drug Information Association

The Japanese Society of Pharmacognosy (JSP)

American Society of Consultant Pharmacists

American College of Clinical Pharmacy

Major Biomedicine Related Research Units in Japan:

The Japanese society of clinical Pharmacology and Therapeutic

Nippon Pharmacy Association

Department of Kampo medicines

Target Audience:

Directors/Managers & Business Delegates, Medicine specialist, Pharmacist, Microbiologist, Pathologist, Immunologist, Director of Laboratories, Universities, Industries, Investigators, Post-Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies, Medicine and Pharmacy companies.

Rise in the number of clinical trials, toxicological studies, and health awareness for nutritional products, rapid growth of Pharmacy data analysis software and solutions, and use of Pharmacotherapy as diagnostics tool for biomarker screening of diseases is expected to propel the growth of this market.

The market is mainly driven by the increasing research funding for Medicine and Pharmacy from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibits the growth of the Pharmacy market to a certain extent. Pharmaceutical science is used extensively in biomarker discovery and drug assessment. Thus, the rapid growth experienced by pharmaceutical and biotechnology industries is assisting the growth of the Medicine market.

In 2013, North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European .

Pharmacy market. However, the Asia-Pacific region represents a significant growth opportunity for the Pharmacy market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.

North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European Pharmacy market. However, the Asia-Pacific region represents a significant growth opportunity for the medicine market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.

The major players in the Medicine and Pharmacotherapy- Regeneron Pharmaceuticals, Vertex Pharmaceuticals, Shire Plc, Bristol-Myers Squibb, Novo Nordisk, Amgen, Johnson & Johnson, Teva Pharmaceutical Industries Ltd.

Fund Allotment towards Medicine and Pharmacy Research:

The National Institutes of Health has provided tens of millions of dollars in new funding to support three new Comprehensive Pharmacy Centers at Mayo Clinic, the University of Kentucky, and the University of Florida.

These three centers will receive an estimated $9 million to $10 million each over the next five years to create resources and initiate research programs that will ramp up the national Pharmaceutical science capabilities.

NIH provided $14.3 million to fund the launch of three other Pharmacy resource centers at the University of Michigan, the Research Triangle Institute, and the University of California, Davis.

Michigan Medicine
NIH West Coast Pharmacy - Centre for Molecular and Genomic Imaging (CMGI)
Southeast Centre for Integrative Medicine (SECIM)
Pharmacokinetics Core at Mayo Clinic
Funding to UC San Diego for this project is $6 million over five years, part of a total investment by the NIH of $51.4 for the Pharmacy project. The awards are supported by the NIH Common Fund.
Biomedical Diagnostics is engaged in a study called Improved, which has received €6m in European FP7 funding.

Mayo Clinic is one of six new federally-funded Comprehensive Pharmacy centers to support medical research on Pharmacotherapy— the study, at the cellular level, of how drugs are metabolized in the body. The award from the National Institutes of Health (NIH) is for $8.8 million over five years.

Pharmaceutical Sciences 2017

11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry is scheduled to take place in the beautiful city of Amsterdam, Netherlands during February 27- 28, 2017 which focuses on foremost topics such as Drug Discovery, Drug Development, Pharmaceutical Engineering, Pharmaceutical Supply Chain Optimization, Pharmaceutical Process Validation Pharma and Biotech Financial Outlook, Digital Pharma, R&D Advancement: Road to New Medicines, Clinical Pharmacy and Therapeutics and Pharmaceutical Sciences.

Conference Series llc Ltd coordinates 1000+ Global events. Every Year across USA, Asia & Europe with support from more than 1000 scientific societies and Publishes more than 700 Open access journals which involves over 100000 eminent personalities, distinguished scientists as editorial board and organizing committee members. Conference Series Ltd is authorized by International Congress and Convention Association. World Congress & International conference as momentously captivated by Nobel Laureate, International Symposiums and Workshops, Exhibitions, Keynote gatherings and Delegates.

Conference Series llc Ltd graciously invites all the participants to this conference. The past International conferences on Pharmacy concentrated on diverse areas related to Pharmacy and their broad applications which have drawn protruding speakers which include esteemed scientists from top International Universities and professionals from dominant associations. Conferences that formerly organized can be found in conference series webpage.

The Global Pharmaceutical market is predicted to reach $4.2 billion by the end of 2014 and to reach $6.8 Billion by 2017. Aspects such as increasing government initiatives and funding, and flourishing use of Pharmaceutical development and drug discovery processes are leading to expansion of the market. However, factors such as inadequacy of skilled personnel to ensure appropriate use of Pharmaceutical tools.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	August 06-07, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View

Media Partners

Association with

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

Testimonials

Very interesting conference which contain several scientific topics and new research and I had a good time in Dubai very much.I hope Iâ€™ll join the next conference also, thank you.
Stojan Rendevski Higher Colleges of Technology UAE

I thoroughly enjoyed the conference and the many nice participants that I met at the meeting that were in attendance. I hope to meet again in the next conference in 2018
Marios Kyriazis ELPIs Foundation for Indefinite Lifespans UK

Thank you for your kind email. It was a very nice conference., everything went well.
Zena M. Fahmi Qaragholi University of Baghdad Iraq

I had a lovely time, thank you so much for inviting me to your esteemed event.
Isaac Karimi Razi University Iran

I greatly appreciate your assistance for this conference and it was quite enjoyable
Mohamed Ismail Nounou Appalachian College of Pharmacy USA

International Conference on Biomedicine & Pharmacotherapy August 06-07, 2018 Osaka, Japan

Recommended Global Pharmaceutical Sciences Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Biomedicine 2018

Track-11: Pharmacotherapy

Track-13: Pharmacological Sciences

Related Pharma Conferences | Pharmaceutical Meetings:

Track-14: Pharmaceutical Technology

Track-18: Industrial Pharmacy

Welcome Message
Bio Medicine 2018

Dr Sergey Suchkov, MD, PhD

Professor in Medicine,
Director, Center for Personalized Medicine,
Sechenov Univercity, and Chair,
Department for Translational Medicine,
Moscow Engineering Physical Institute (MEPhI), Moscow, Russia,
Secretary General, United Cultural Convention (UCC), Cambridge, UK

Conference Highlights

To Collaborate Scientific Professionals around the World

Media Partners

Association with

Association with

Association with

Useful Links

Special Issues

Testimonials

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Biomedicine 2018

Track-11: Pharmacotherapy

Track-13: Pharmacological Sciences

Related Pharma Conferences | Pharmaceutical Meetings:

Track-14: Pharmaceutical Technology

Track-18: Industrial Pharmacy

Welcome Message Bio Medicine 2018

Dr Sergey Suchkov, MD, PhD

Professor in Medicine, Director, Center for Personalized Medicine, Sechenov Univercity, and Chair, Department for Translational Medicine, Moscow Engineering Physical Institute (MEPhI), Moscow, Russia, Secretary General, United Cultural Convention (UCC), Cambridge, UK

Conference Highlights

To Collaborate Scientific Professionals around the World

Media Partners

Association with

Association with

Association with

Useful Links

Special Issues

Testimonials

Welcome Message
Bio Medicine 2018

Professor in Medicine,
Director, Center for Personalized Medicine,
Sechenov Univercity, and Chair,
Department for Translational Medicine,
Moscow Engineering Physical Institute (MEPhI), Moscow, Russia,
Secretary General, United Cultural Convention (UCC), Cambridge, UK